Sean Scanlan Biography and Net Worth

Sean F. Scanlan, PhD has over 14 years of orthopaedic research and product development experience. Mr. Scanlan has served as our Senior Vice President, Marketing & Medical Education since March 2021 and before that as our Vice President, Marketing & Medical Education since January 2018, after serving in various marketing roles of increasing responsibility since December 2014. Prior to joining our company, Mr. Scanlan spent 3 years in Research & Development at Smith & Nephew’s Advanced Surgical Devices division focused on product development and early-stage technology assessment. Before that, he led an interdisciplinary clinical research study at Stanford University with the Orthopaedic Surgery and Engineering departments, focusing on orthopaedic surgery and engineering, and served as a consultant for an early-stage orthopaedics start-up company, Moximed, Inc. Mr. Scanlan holds a B.S. in Engineering Science (Biomechanics) from the University of Florida, and an M.S. and PhD in Mechanical Engineering (Biomechanical Engineering division) from Stanford University.

What is Sean F. Scanlan's net worth?: The estimated net worth of Sean F. Scanlan is at least $3.09 million as of March 17th, 2025. Dr. Scanlan owns 364,081 shares of Treace Medical Concepts stock worth more than $3,094,689 as of March 26th. This net worth evaluation does not reflect any other investments that Dr. Scanlan may own. Learn More about Sean F. Scanlan's net worth.
How old is Sean F. Scanlan?: Dr. Scanlan is currently 42 years old. There are 7 older executives and no younger executives at Treace Medical Concepts. The oldest executive at Treace Medical Concepts is Ms. Julie D. Dewey, Chief Communications & Investor Relations Officer, who is 63 years old. Learn More on Sean F. Scanlan's age.
How do I contact Sean F. Scanlan?: The corporate mailing address for Dr. Scanlan and other Treace Medical Concepts executives is 203 FORT WADE RD. SUITE 150, PONTE VEDRA FL, 32081. Treace Medical Concepts can also be reached via phone at 904-373-5940 and via email at ir@treace.net. Learn More on Sean F. Scanlan's contact information.
Has Sean F. Scanlan been buying or selling shares of Treace Medical Concepts?: Over the course of the past ninety days, Sean F. Scanlan has sold $398,500.00 of Treace Medical Concepts stock. Most recently, Sean F. Scanlan sold 50,000 shares of the business's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $7.97, for a transaction totalling $398,500.00. Following the completion of the sale, the insider now directly owns 364,081 shares of the company's stock, valued at $2,901,725.57. Learn More on Sean F. Scanlan's trading history.
Who are Treace Medical Concepts' active insiders?: Treace Medical Concepts' insider roster includes Sean Scanlan (SVP), Thomas Timbie (Director), James Treace (Director), John Treace (CEO), and John Treace (Director). Learn More on Treace Medical Concepts' active insiders.
Are insiders buying or selling shares of Treace Medical Concepts?: During the last twelve months, Treace Medical Concepts insiders bought shares 12 times. They purchased a total of 812,902 shares worth more than $4,206,561.76. During the last twelve months, insiders at the sold shares 1 times. They sold a total of 50,000 shares worth more than $398,500.00. The most recent insider tranaction occured on March, 17th when insider Sean F Scanlan sold 50,000 shares worth more than $398,500.00. Insiders at Treace Medical Concepts own 24.4% of the company. Learn More about insider trades at Treace Medical Concepts.
Information on this page was last updated on 3/17/2025.

Sean F. Scanlan Insider Trading History at Treace Medical Concepts

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/17/2025	Sell	50,000	$7.97	$398,500.00	364,081
5/16/2023	Sell	25,000	$25.44	$636,000.00	32,395
2/15/2023	Sell	25,000	$21.69	$542,250.00	9,975
1/12/2023	Sell	25,000	$25.57	$639,250.00	9,975
11/14/2022	Sell	25,000	$24.27	$606,750.00	9,975
3/2/2022	Sell	25,000	$20.82	$520,500.00
2/9/2022	Sell	3,873	$20.16	$78,079.68
1/10/2022	Sell	38,862	$20.16	$783,457.92
1/5/2022	Sell	800	$20.02	$16,016.00
1/3/2022	Sell	1,000	$20.02	$20,020.00
11/10/2021	Sell	25,000	$21.54	$538,500.00

Sean F. Scanlan Buying and Selling Activity at Treace Medical Concepts

Treace Medical Concepts Company Overview

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Today's Range

Now: $8.58

$8.34

$8.63

50 Day Range

MA: $9.24

$7.94

$10.54

2 Week Range

Now: $8.58

$3.92

$13.24

Volume

323,557 shs

Average Volume

728,931 shs

Market Capitalization

$537.27 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.77

Sean Scanlan Biography and Net Worth

What is Sean F. Scanlan's net worth?

How old is Sean F. Scanlan?

How do I contact Sean F. Scanlan?

Has Sean F. Scanlan been buying or selling shares of Treace Medical Concepts?

Who are Treace Medical Concepts' active insiders?

Are insiders buying or selling shares of Treace Medical Concepts?